Investment & deals

Xella Health has integrated Oura wearable data into its women’s health platform, allowing members to share trends with clinicians alongside diagnostic results. Members can choose to share information including sleep, heart rate variability, resting heart rate, temperature trends, recovery, activity and menstrual-cycle data. The integration is intended to help clinicians investigate biological factors that may [...]

Women’s health medical device company Ark Surgical has secured further institutional backing from JNF and the Israel Innovation Authority (IIA) as it accelerates the US commercial expansion of its surgical tissue containment technology. Both organisations have previously backed Ark, making the renewed support a significant vote of confidence in the company’s technology, leadership team and [...]

Calla Lily Clinical Care has joined a US$50m antibiotics programme to assess vaginal delivery of UTI treatments through its Callavid platform. The women’s health medical technology company will evaluate whether antibiotics can be delivered directly through the vaginal wall to treat urinary tract infections (UTIs). The project will use Callavid, the company’s intravaginal drug delivery [...]

Cambridge health tech company TidalSense has secured £14.2m in funding led by Cross-Border Impact Ventures to expand its AI-powered lung disease test across the NHS and into Europe and the US. The investment, which also includes returning backers BGF, Airstream Capital and Foresight Group, will fund the rollout of a handheld diagnostic device that can [...]

Women’s health startup Ovum has raised US$4m in seed funding to develop its AI health journal and expand research using women’s health data. The round valued the Melbourne startup at US$18m. Ovum plans to use the funding to develop its artificial intelligence technology and longitudinal datasets, which track health information over time to reveal changes [...]

Future Fertility, a Toronto-based health technology company specialising in AI-powered fertility insights, has entered the Japanese market through a new commercial partnership with Kato Ladies Clinic — a globally recognised leader in IVF research and advancing clinical fertility care. The collaboration marks Future Fertility’s first partnership in Japan and reflects growing global demand for technologies [...]

Australian startup Proseek Bio has raised AU$1.5m in an oversubscribed seed round to commercialise its ovarian cancer blood test. With up to 80 per cent of surgeries for suspected ovarian cancer coming back benign, the company says better diagnostics are urgently needed. Proseek Bio says its test is designed to support earlier and more precise [...]

Teijin Pharma and Aska Pharmaceutical have teamed up on small-molecule drugs research for gynaecological diseases, combining AI-led design with clinical tests. The collaboration pairs Teijin Pharma’s AI-driven drug discovery and computer-aided molecular design with Aska Pharmaceutical’s expertise in obstetrics and gynaecology. The work will focus on early-stage drug discovery, identifying and optimising small-molecule compounds that [...]

Wysa has secured £5.3m to adapt a digital mental health programme for adolescent girls in rural India. The funding comes from Wellcome and will support a scale-up study to tailor a clinically validated digital intervention for girls facing limited autonomy, restricted access to technology, lower literacy, stigma and family gatekeeping. Digital interventions are app-based programmes [...]

Women's telehealth company Wisp has acquired TBD Health, a sexual health platform, in its first acquisition and expansion beyond direct-to-consumer care. The deal adds TBD Health's diagnostics infrastructure and hospital partnerships to Wisp's platform, which the company says serves 1.8 million patients across the US. Wisp, which describes itself as the largest women's telehealth company [...]